Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 CAR T-cell therapy

Radiotherapy is potentially an important salvage strategy post-chimeric antigen receptor T-cell therapy (CART) but limited data exist. We reviewed 14 patients treated with salvage radiation post-CART progression (SRT). Most received SRT for first post-CART relapse (71%) to sites previously PET-avid...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Haematol
Asıl Yazarlar: Imber, Brandon S., Sadelain, Michel, DeSelm, Carl, Batlevi, Connie, Brentjens, Renier J., Dahi, Parastoo B., Giralt, Sergio, Park, Jae H., Sauter, Craig, Scordo, Michael, Shah, Gunjan, Perales, Miguel-Angel, Palomba, M. Lia, Yahalom, Joachim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329607/
https://ncbi.nlm.nih.gov/pubmed/32135029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16541
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller